HRTX - Heron Therapeutics Inc. (HRTX) CEO Barry Quart on Q3 2021 Results - Earnings Call Transcript
Heron Therapeutics, Inc. (HRTX) Q3 2021 Results Earnings Conference Call November 03, 2021, 04:15 PM ET Company Participants David Szekeres - Executive Vice President, Chief Operating Officer Barry Quart - Chief Executive Officer and Chairman of the Board John Poyhonen - President and Chief Commercial Officer; Kimberly Manhard - Executive Vice President, Drug Development and Director Conference Call Participants Joshua Schimmer - Evercore ISI Brandon Folkes - Cantor Fitzgerald Boris Peaker - Cowen Serge Belanger - Needham & Company Kelly Shi - Jefferies Josh Schimmer - Evercore ISI Presentation Operator Good day, ladies and gentlemen, and thank you for standing by. Welcome to the Heron Therapeutics Q3 2021 Earnings Conference. As a reminder, this conference is being recorded. Now I would like to turn the call over to David Szekeres, Executive Vice President, Chief Operating Officer. Please proceed. David Szekeres Thank you, Gigi. Good afternoon, everyone, and thank you for
For further details see:
Heron Therapeutics, Inc. (HRTX) CEO Barry Quart on Q3 2021 Results - Earnings Call Transcript